Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.65
Delayed Data
As of Apr 24
 -0.10 / -3.64%
Today’s Change
2.51
Today|||52-Week Range
7.70
-52.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$10.2M

Company Description

RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Contact Information

RXi Pharmaceuticals Corp.
257 Simarano Drive
Marlborough Massachusetts 01752
P:(508) 767-3861
Investor Relations:
(508) 929-3646

Employees

Shareholders

Other institutional24.03%
Mutual fund holders0.51%
Individual stakeholders--

Top Executives

Geert CauwenberghPresident, CEO, CFO & Director
Karen BulockVice President-Research
Gerrit DispersynChief Development Officer
James CardiaDirector-Business Development
Caitlin KontulisSecretary & Principal Accounting Officer